New cDAT application for for automated quantification of DAT SPECT images further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.
Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the launch of…
Combinostics has been selected to join the 2019 MassChallenge HealthTech cohort which represents the most innovative technologies advancing health and improving the overall patient experience.
Combinostics is pleased to announce the release of version 1.4.0 of the cNeuro suite of tools. The upgrade provides new access to cMRI features and features improved classification algorithms in cDSI.
Combinostics and Siemens Healthineers are partnering to distribute Combinostic’s cNeuro cMRI application through the Siemens Healthineers Digital Ecosystem.
The US FDA has issued 510(k) clearance for Combinostic's image quantification software cNeuro cMRI.
Combinostics is pleased to announce the launch of cDSI, a tool for providing clinical decision support in neurological disorders.
Combinostics is pleased to announce the launch of cMRI, a tool for quantitative assessment of MRI brain images. cMRI is a module in cNeuro, Combinostics’ suite of tools for quantitative assessment of brain images.
Combinostics US Inc.
177 Huntington Ave
17th Floor
Boston, MA 02115, USA
© Combinostics | Privacy Policy
